8-K: Sanuwave Health Stockholders Approve Merger with SEP Acquisition Corp.

Sanuwave Health, Inc. stockholders have approved the merger with SEP Acquisition Corp., paving the way for the company to become a subsidiary of SEPA.

Summary

• Sanuwave Health, Inc. held a special meeting on February 21, 2024, where stockholders voted on two proposals related to the merger with SEP Acquisition Corp.
• Proposal 1, the Business Combination Proposal, was approved with 798,379,869 votes for, 5,221,765 against, and 71,525 abstaining.
• Proposal 2, to adjourn the meeting if necessary, was also approved with 797,802,452 votes for, 5,792,907 against, and 77,800 abstaining, but was not needed due to sufficient votes for Proposal 1.
• The merger will result in Sanuwave Health becoming a subsidiary of SEP Acquisition Corp.
• The company will continue as the surviving entity of the Business Combination.

Sentiment

Score: 7

Explanation: The document reports a successful vote for the merger, which is a positive development. However, it also includes cautionary language about risks and uncertainties, which tempers the overall sentiment.

Positives

• The merger with SEP Acquisition Corp. was approved by Sanuwave Health stockholders.
• The required votes were secured without needing to adjourn the special meeting.

Risks

• The merger agreement could be terminated due to various events or circumstances.
• The Business Combination may not be completed if SEPA does not have at least $12.0 million at closing.
• There could be delays in obtaining necessary regulatory approvals.
• SEPA's securities may not be listed on Nasdaq after the merger.
• The company may be adversely affected by economic, business, or competitive factors.

Future Outlook

The document includes forward-looking statements regarding the completion of the merger and expected results for the combined company, but cautions that actual results may differ materially due to various risks and uncertainties.

Management Comments

• The company cautions readers not to place undue reliance upon any forward-looking statements.
• The company undertakes no obligation to update or revise the forward-looking statements.

Industry Context

This merger is part of a broader trend of companies seeking to combine with special purpose acquisition companies (SPACs) to gain access to public markets and capital.

Comparison to Industry Standards

• The document does not provide specific financial results to compare against industry standards.
• The merger process is similar to other SPAC transactions, where a private company merges with a publicly listed shell company.

Stakeholder Impact

• Shareholders of Sanuwave Health have approved the merger, which will impact their investment.
• Employees of Sanuwave Health will become part of the combined entity.
• The merger may impact customers and suppliers of Sanuwave Health.

Next Steps

• The companies will work towards satisfying the closing conditions of the merger agreement.
• SEPA will seek to list its securities on Nasdaq following the Business Combination.

Key Dates

Keywords

merger, acquisition, business combination, stockholders, SEPA, Sanuwave Health, voting, proxy